><title>References</title><ref id="b1"><element-citation publication-type="book"><collab>WHO</collab><source>Global Tuberculosis Report 2013</source><year>2013</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO Press</publisher-name></element-citation></ref><ref id="b2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="b3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><name><surname>Walzl</surname><given-names>G</given-names></name><etal/></person-group><article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis</article-title><source>Genes Immun</source><year>2011</year><volume>12</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">20861863</pub-id></element-citation></ref><ref id="b4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Dass</surname><given-names>RH</given-names></name><name><surname>Yang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>MM</given-names></name><name><surname>Wong</surname><given-names>HE</given-names></name><name><surname>Sahiratmadja</surname><given-names>E</given-names></name><name><surname>Khor</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e45839</fpage><pub-id pub-id-type="pmid">23029268</pub-id></element-citation></ref><ref id="b5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>DB</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group><article-title>Type I interferons in host defense</article-title><source>Immunity</source><year>2006</year><volume>25</volume><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">16979569</pub-id></element-citation></ref><ref id="b6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platanias</surname><given-names>LC</given-names></name></person-group><article-title>Mechanisms of type-I- and type-II-interferon-mediated signalling</article-title><source>Nat. Rev. Immunol</source><year>2005</year><volume>5</volume><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">15864272</pub-id></element-citation></ref><ref id="b7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group><article-title>Type I interferon: friend or foe?</article-title><source>J. Exp. Med</source><year>2010</year><volume>207</volume><fpage>2053</fpage><lpage>2063</lpage><pub-id pub-id-type="pmid">20837696</pub-id></element-citation></ref><ref id="b8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Bergtold</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name><name><surname>Barry</surname><given-names>CE</given-names><suffix>III</suffix></name><etal/></person-group><article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>5752</fpage><lpage>5757</lpage><pub-id pub-id-type="pmid">11320211</pub-id></element-citation></ref><ref id="b9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Barczak</surname><given-names>AK</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Barry</surname><given-names>C</given-names></name><etal/></person-group><article-title>Hypervirulent <italic>M. tuberculosis</italic> W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title><source>J. Interferon. Cytokine Res</source><year>2005</year><volume>25</volume><fpage>694</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">16318583</pub-id></element-citation></ref><ref id="b10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>LR</given-names></name><name><surname>Gigliotti</surname><given-names>RA</given-names></name><name><surname>Goncalves</surname><given-names>R</given-names></name><name><surname>Roffe</surname><given-names>E</given-names></name><name><surname>Cheever</surname><given-names>AW</given-names></name><name><surname>Bafica</surname><given-names>A</given-names></name><name><surname>Salazar</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title><source>J. Clin. Invest</source><year>2010</year><volume>120</volume><fpage>1674</fpage><lpage>1682</lpage><pub-id pub-id-type="pmid">20389020</pub-id></element-citation></ref><ref id="b11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><name><surname>Brooks</surname><given-names>JV</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group><article-title>Expression of the nitric oxide synthase 2 gene is not essential for early control of <italic>Mycobacterium tuberculosis</italic> in the murine lung</article-title><source>Infect. Immun</source><year>2000</year><volume>68</volume><fpage>6879</fpage><lpage>6882</lpage><pub-id pub-id-type="pmid">11083808</pub-id></element-citation></ref><ref id="b12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SA</given-names></name><name><surname>Johndrow</surname><given-names>JE</given-names></name><name><surname>Manzanillo</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group><article-title>The Type I IFN response to infection with <italic>Mycobacterium tuberculosis</italic> requires ESX-1-mediated secretion and contributes to pathogenesis</article-title><source>J. Immunol</source><year>2007</year><volume>178</volume><fpage>3143</fpage><lpage>3152</lpage><pub-id pub-id-type="pmid">17312162</pub-id></element-citation></ref><ref id="b13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group><article-title>The expression of early resistance to an infection with <italic>Mycobacterium tuberculosis</italic> by old mice is dependent on IFN type II (IFN-gamma) but not IFN type I</article-title><source>Mech. Ageing Dev</source><year>2004</year><volume>125</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14706232</pub-id></element-citation></ref><ref id="b14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RM</given-names></name><name><surname>Graeber</surname><given-names>TG</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Montoya</surname><given-names>D</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><name><surname>Komisopoulou</surname><given-names>E</given-names></name><etal/></person-group><article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>1448</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">23449998</pub-id></element-citation></ref><ref id="b15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><name><surname>Oland</surname><given-names>S</given-names></name><etal/></person-group><article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="pmid">22195750</pub-id></element-citation></ref><ref id="b16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group><article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis</italic></article-title><source>J. Immunol</source><year>2012</year><volume>188</volume><fpage>6205</fpage><lpage>6215</lpage><pub-id pub-id-type="pmid">22566567</pub-id></element-citation></ref><ref id="b17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name></person-group><article-title>Immunology of tuberculosis</article-title><source>Annu. Rev. Immunol</source><year>2001</year><volume>19</volume><fpage>93</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">11244032</pub-id></element-citation></ref><ref id="b18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eden</surname><given-names>E</given-names></name><name><surname>Navon</surname><given-names>R</given-names></name><name><surname>Steinfeld</surname><given-names>I</given-names></name><name><surname>Lipson</surname><given-names>D</given-names></name><name><surname>Yakhini</surname><given-names>Z</given-names></name></person-group><article-title>GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists</article-title><source>BMC Bioinformatics</source><year>2009</year><volume>10</volume><fpage>48</fpage><pub-id pub-id-type="pmid">19192299</pub-id></element-citation></ref><ref id="b19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeyaseelan</surname><given-names>S</given-names></name><name><surname>Manzer</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>SK</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Mason</surname><given-names>RJ</given-names></name><name><surname>Worthen</surname><given-names>GS</given-names></name></person-group><article-title>Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium</article-title><source>Am. J. Respir. Cell Mol. Biol</source><year>2005</year><volume>32</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">15778492</pub-id></element-citation></ref><ref id="b20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balamayooran</surname><given-names>G</given-names></name><name><surname>Batra</surname><given-names>S</given-names></name><name><surname>Fessler</surname><given-names>MB</given-names></name><name><surname>Happel</surname><given-names>KI</given-names></name><name><surname>Jeyaseelan</surname><given-names>S</given-names></name></person-group><article-title>Mechanisms of neutrophil accumulation in the lungs against bacteria</article-title><source>Am. J. Respir. Cell Mol. Biol</source><year>2010</year><volume>43</volume><fpage>5</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">19738160</pub-id></element-citation></ref><ref id="b21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Tewary</surname><given-names>P</given-names></name><name><surname>Howard</surname><given-names>OM</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name></person-group><article-title>Alarmin-induced cell migration</article-title><source>Eur. J. Immunol</source><year>2013</year><volume>43</volume><fpage>1412</fpage><lpage>1418</lpage><pub-id pub-id-type="pmid">23619968</pub-id></element-citation></ref><ref id="b22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>EM</given-names></name><name><surname>Linder</surname><given-names>CC</given-names></name><name><surname>Sargent</surname><given-names>EE</given-names></name><name><surname>Davisson</surname><given-names>MT</given-names></name><name><surname>Mobraaten</surname><given-names>LE</given-names></name><name><surname>Sharp</surname><given-names>JJ</given-names></name></person-group><article-title>Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice</article-title><source>Nat. Genet</source><year>1997</year><volume>16</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">9140391</pub-id></element-citation></ref><ref id="b23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>E</given-names></name><name><surname>North</surname><given-names>RJ</given-names></name></person-group><article-title>Resistance ranking of some common inbred mouse strains to <italic>Mycobacterium tuberculosis</italic> and relationship to major histocompatibility complex haplotype and Nramp1 genotype</article-title><source>Immunology</source><year>1998</year><volume>93</volume><fpage>270</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">9616378</pub-id></element-citation></ref><ref id="b24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>U</given-names></name><name><surname>Steinhoff</surname><given-names>U</given-names></name><name><surname>Reis</surname><given-names>LF</given-names></name><name><surname>Hemmi</surname><given-names>S</given-names></name><name><surname>Pavlovic</surname><given-names>J</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name><name><surname>Aguet</surname><given-names>M</given-names></name></person-group><article-title>Functional role of type I and type II interferons in antiviral defense</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>1918</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">8009221</pub-id></element-citation></ref><ref id="b25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>GP</given-names></name><name><surname>Bruce</surname><given-names>AT</given-names></name><name><surname>Sheehan</surname><given-names>KC</given-names></name><name><surname>Shankaran</surname><given-names>V</given-names></name><name><surname>Uppaluri</surname><given-names>R</given-names></name><name><surname>Bui</surname><given-names>JD</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><etal/></person-group><article-title>A critical function for type I interferons in cancer immunoediting</article-title><source>Nat. Immunol</source><year>2005</year><volume>6</volume><fpage>722</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">15951814</pub-id></element-citation></ref><ref id="b26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahangian</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>EK</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>JR</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><name><surname>Belperio</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title><source>J. Clin. Invest</source><year>2009</year><volume>119</volume><fpage>1910</fpage><lpage>1920</lpage><pub-id pub-id-type="pmid">19487810</pub-id></element-citation></ref><ref id="b27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weighardt</surname><given-names>H</given-names></name><name><surname>Kaiser-Moore</surname><given-names>S</given-names></name><name><surname>Schlautkotter</surname><given-names>S</given-names></name><name><surname>Rossmann-Bloeck</surname><given-names>T</given-names></name><name><surname>Schleicher</surname><given-names>U</given-names></name><name><surname>Bogdan</surname><given-names>C</given-names></name><name><surname>Holzmann</surname><given-names>B</given-names></name></person-group><article-title>Type I IFN modulates host defense and late hyperinflammation in septic peritonitis</article-title><source>J. Immunol</source><year>2006</year><volume>177</volume><fpage>5623</fpage><lpage>5630</lpage><pub-id pub-id-type="pmid">17015750</pub-id></element-citation></ref><ref id="b28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Joyee</surname><given-names>AG</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>H</given-names></name><name><surname>Jiao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Type I IFNs enhance susceptibility to <italic>Chlamydia muridarum</italic> lung infection by enhancing apoptosis of local macrophages</article-title><source>J. Immunol</source><year>2008</year><volume>181</volume><fpage>2092</fpage><lpage>2102</lpage><pub-id pub-id-type="pmid">18641348</pub-id></element-citation></ref><ref id="b29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majer</surname><given-names>O</given-names></name><name><surname>Bourgeois</surname><given-names>C</given-names></name><name><surname>Zwolanek</surname><given-names>F</given-names></name><name><surname>Lassnig</surname><given-names>C</given-names></name><name><surname>Kerjaschki</surname><given-names>D</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>M</given-names></name><etal/></person-group><article-title>Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during <italic>Candida</italic> infections</article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><fpage>e1002811</fpage><pub-id pub-id-type="pmid">22911155</pub-id></element-citation></ref><ref id="b30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PY</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Weinstein</surname><given-names>JS</given-names></name><name><surname>Kellner</surname><given-names>ES</given-names></name><name><surname>Nacionales</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Type I interferon modulates monocyte recruitment and maturation in chronic inflammation</article-title><source>Am. J. Pathol</source><year>2009</year><volume>175</volume><fpage>2023</fpage><lpage>2033</lpage><pub-id pub-id-type="pmid">19808647</pub-id></element-citation></ref><ref id="b31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Zerrahn</surname><given-names>J</given-names></name><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Fae</surname><given-names>KC</given-names></name><name><surname>Arrey</surname><given-names>F</given-names></name><etal/></person-group><article-title>CXCL5/LIX-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis</article-title><source>J. Clin. Invest</source><year>2014</year><volume>124</volume><fpage>1268</fpage><lpage>1282</lpage><pub-id pub-id-type="pmid">24509076</pub-id></element-citation></ref><ref id="b32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>N</given-names></name><name><surname>McComb</surname><given-names>S</given-names></name><name><surname>Mulligan</surname><given-names>R</given-names></name><name><surname>Dudani</surname><given-names>R</given-names></name><name><surname>Krishnan</surname><given-names>L</given-names></name><name><surname>Sad</surname><given-names>S</given-names></name></person-group><article-title>Type I interferon induces necroptosis in macrophages during infection with <italic>Salmonella enterica</italic> serovar Typhimurium</article-title><source>Nat. Immunol</source><year>2012</year><volume>13</volume><fpage>954</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">22922364</pub-id></element-citation></ref><ref id="b33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname><given-names>FJ</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><article-title>TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">23582643</pub-id></element-citation></ref><ref id="b34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Desel</surname><given-names>C</given-names></name><name><surname>Yeremeev</surname><given-names>V</given-names></name><name><surname>Pradl</surname><given-names>L</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Mollenkopf</surname><given-names>HJ</given-names></name><name><surname>Hanke</surname><given-names>K</given-names></name><etal/></person-group><article-title>The adaptor molecule CARD9 is essential for tuberculosis control</article-title><source>J. Exp. Med</source><year>2010</year><volume>207</volume><fpage>777</fpage><lpage>792</lpage><pub-id pub-id-type="pmid">20351059</pub-id></element-citation></ref><ref id="b35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Iannaccone</surname><given-names>M</given-names></name><name><surname>Farinacci</surname><given-names>M</given-names></name><name><surname>Fae</surname><given-names>KC</given-names></name><name><surname>Schreiber</surname><given-names>J</given-names></name><name><surname>Moura-Alves</surname><given-names>P</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><etal/></person-group><article-title>MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment</article-title><source>J. Clin. Invest</source><year>2013</year><volume>123</volume><fpage>4836</fpage><lpage>4848</lpage><pub-id pub-id-type="pmid">24084739</pub-id></element-citation></ref><ref id="b36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abadie</surname><given-names>V</given-names></name><name><surname>Badell</surname><given-names>E</given-names></name><name><surname>Douillard</surname><given-names>P</given-names></name><name><surname>Ensergueix</surname><given-names>D</given-names></name><name><surname>Leenen</surname><given-names>PJ</given-names></name><name><surname>Tanguy</surname><given-names>M</given-names></name><name><surname>Fiette</surname><given-names>L</given-names></name><etal/></person-group><article-title>Neutrophils rapidly migrate via lymphatics after <italic>Mycobacterium bovis</italic> BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes</article-title><source>Blood</source><year>2005</year><volume>106</volume><fpage>1843</fpage><lpage>1850</lpage><pub-id pub-id-type="pmid">15886329</pub-id></element-citation></ref><ref id="b37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telesca</surname><given-names>C</given-names></name><name><surname>Angelico</surname><given-names>M</given-names></name><name><surname>Piccolo</surname><given-names>P</given-names></name><name><surname>Nosotti</surname><given-names>L</given-names></name><name><surname>Morrone</surname><given-names>A</given-names></name><name><surname>Longhi</surname><given-names>C</given-names></name><name><surname>Carbone</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant</article-title><source>J. Infect</source><year>2007</year><volume>54</volume><fpage>e223</fpage><lpage>e226</lpage><pub-id pub-id-type="pmid">17307255</pub-id></element-citation></ref><ref id="b38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babudieri</surname><given-names>S</given-names></name><name><surname>Soddu</surname><given-names>A</given-names></name><name><surname>Murino</surname><given-names>M</given-names></name><name><surname>Molicotti</surname><given-names>P</given-names></name><name><surname>Muredda</surname><given-names>AA</given-names></name><name><surname>Madeddu</surname><given-names>G</given-names></name><name><surname>Fois</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Tuberculosis screening before anti-hepatitis C virus therapy in prisons</article-title><source>Emerg. Infect. Dis</source><year>2012</year><volume>18</volume><fpage>689</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">22469015</pub-id></element-citation></ref><ref id="b39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkahla</surname><given-names>N</given-names></name><name><surname>Kchir</surname><given-names>H</given-names></name><name><surname>Maamouri</surname><given-names>N</given-names></name><name><surname>Ouerghi</surname><given-names>H</given-names></name><name><surname>Hariz</surname><given-names>FB</given-names></name><name><surname>Chouaib</surname><given-names>S</given-names></name><name><surname>Chaabouni</surname><given-names>H</given-names></name><etal/></person-group><article-title>Reactivation of tuberculosis during dual therapy with pegylated interferon and ribavirin for chronic hepatitis C</article-title><source>Rev. Med. Interne</source><year>2010</year><volume>31</volume><fpage>e1</fpage><lpage>e3</lpage><pub-id pub-id-type="pmid">20605283</pub-id></element-citation></ref><ref id="b40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giosue</surname><given-names>S</given-names></name><name><surname>Casarini</surname><given-names>M</given-names></name><name><surname>Alemanno</surname><given-names>L</given-names></name><name><surname>Galluccio</surname><given-names>G</given-names></name><name><surname>Mattia</surname><given-names>P</given-names></name><name><surname>Pedicelli</surname><given-names>G</given-names></name><name><surname>Rebek</surname><given-names>L</given-names></name><etal/></person-group><article-title>Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis</article-title><source>Am. J. Respir. Crit. Care Med</source><year>1998</year><volume>158</volume><fpage>1156</fpage><lpage>1162</lpage><pub-id pub-id-type="pmid">9769275</pub-id></element-citation></ref><ref id="b41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmero</surname><given-names>D</given-names></name><name><surname>Eiguchi</surname><given-names>K</given-names></name><name><surname>Rendo</surname><given-names>P</given-names></name><name><surname>Castro</surname><given-names>ZL</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><name><surname>Gonzalez Montaner</surname><given-names>LJ</given-names></name></person-group><article-title>Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up</article-title><source>Int. J. Tuberc. Lung Dis</source><year>1999</year><volume>3</volume><fpage>214</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">10094322</pub-id></element-citation></ref><ref id="b42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhukova</surname><given-names>EM</given-names></name><name><surname>Krasnov</surname><given-names>VA</given-names></name><name><surname>Petrenko</surname><given-names>TI</given-names></name><name><surname>Romanov</surname><given-names>VV</given-names></name></person-group><article-title>Interferon alpha-2b in the complex therapy of patients with pulmonary tuberculosis concurrent with bronchoobstructive syndrome</article-title><source>Probl. Tuberk. Bolezn. Legk</source><year>2009</year><volume>12</volume><fpage>58</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">20095375</pub-id></element-citation></ref><ref id="b43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Lin</surname><given-names>MC</given-names></name><name><surname>Hung</surname><given-names>CH</given-names></name></person-group><article-title>Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis</article-title><source>J. Formos. Med. Assoc</source><year>2009</year><volume>108</volume><fpage>746</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">19773215</pub-id></element-citation></ref><ref id="b44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fejer</surname><given-names>G</given-names></name><name><surname>Drechsel</surname><given-names>L</given-names></name><name><surname>Liese</surname><given-names>J</given-names></name><name><surname>Schleicher</surname><given-names>U</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Imelli</surname><given-names>N</given-names></name><name><surname>Greber</surname><given-names>UF</given-names></name><etal/></person-group><article-title>Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000208</fpage><pub-id pub-id-type="pmid">19008951</pub-id></element-citation></ref><ref id="b45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname><given-names>L</given-names></name><name><surname>Baulard</surname><given-names>A</given-names></name><name><surname>Estaquier</surname><given-names>J</given-names></name><name><surname>Poulain-Godefroy</surname><given-names>O</given-names></name><name><surname>Locht</surname><given-names>C</given-names></name></person-group><article-title>Green fluorescent protein as a new expression marker in mycobacteria</article-title><source>Mol. Microbiol</source><year>1995</year><volume>17</volume><fpage>913</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">8596440</pub-id></element-citation></ref><ref id="b46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Hagens</surname><given-names>K</given-names></name><name><surname>Heinemann</surname><given-names>E</given-names></name><name><surname>Pradl</surname><given-names>L</given-names></name><name><surname>Oberbeck-Muller</surname><given-names>D</given-names></name><etal/></person-group><article-title>Activation of the NLRP3 inflammasome by <italic>Mycobacterium tuberculosis</italic> is uncoupled from susceptibility to active tuberculosis</article-title><source>Eur. J. Immunol</source><year>2012</year><volume>42</volume><fpage>374</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">22101787</pub-id></element-citation></ref><ref id="b47"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>V</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name><name><surname>Irizarry</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><article-title>Limma: linear models for microarray data</article-title><source>Bioinformatics and computational biology solutions using R and bioconductor</source><year>2005</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>397</fpage><lpage>420</lpage></element-citation></ref><ref id="b48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>J. Roy. Stat. Soc</source><year>1995</year><volume>57</volume><fpage>289</fpage><lpage>300</lpage></element-citation></ref><ref id="b49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Draghici</surname><given-names>S</given-names></name><name><surname>Khatri</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Mittal</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>A novel signaling pathway impact analysis</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">18990722</pub-id></element-citation></ref></